Drug recall · February 14, 2018
All sterile drug preparations remaining within expiry prepared from Fentanyl Citrate Base Solution dispensed between October 16 recall
Why: Lack of sterility assurance.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
All sterile drug preparations remaining within expiry prepared from Fentanyl Citrate Base Solution dispensed between October 16, 2017 and November 17, 2017 Compounded by Intrathecal Compounding Specialists, Scott, LA 70583.
- Lots / codes
All lots remaining within expiry (BUDs between November 15, 2017 and December 16, 2017)
- Quantity
- Unknown.
- Company
- Intrathecal Compounding Specialist, LLC, Scott, LA
- Distribution
- Nationwide
- Initiated
- November 30, 2017 · Voluntary: Firm initiated
- Classified
- February 4, 2018
- Reported
- February 14, 2018
- Ended
- May 1, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fentanyl
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.